Background. Hypertension is extremely prevalent in patients with diabetes. Limited data exist on utilization patterns of antihypertensive in this population are consistent with evidence-based practice guidelines.
INTRODUCTION
Diabetes mellitus and hypertension are interrelated diseases that strongly predispose an individual to atherosclerotic cardiovascular disease recommends that blood pressure (BP) in diabetics be controlled to levels of 130/80 mmHg or lower 5 . On contrary to above studies, some studies indicate that majority of diabetic patients will require two or more drugs to achieve BP control 8, 10, 11 . The resulting changes in drug use in time and place may have medical, social and economic implications both for the individual patient for populations. These differences need to be identified, explained and corrected if needed. Drug utilization studies are necessary to this effect with a particular focus on socio-demographic characteristics, co-morbid conditions and pattern of anti-hypertensive drugs usage 12 . Thus in this context, the present study was conducted to examine the utilization pattern of antihypertensive in hypertensive diabetic patients and also to explore the adherence of prescribing pattern with existing guidelines.
MATERIALS AND METHODS
This study is a retrospective descriptive cross sectional drug utilization study conducted in the outpatient department at 
Data analysis
Data analysis was carried out using Microsoft excel. Data were expressed as mean (standard deviation) for continuous variables and as frequency for categorical variables.
RESULTS
One hundred forty nine prescriptions belonging to 81 (54.4 %) females and 68 (45.6%) males were studied. The mean age of the male patients included in the study was found to be 55.2±8.5 years and the mean age of the female students included in this study was found to be 58.1 ± 12.9.
The overall use of antihypertensive in diabetes is shown in In Table 3 2 (2.9%) patients were prescribed with β-Blockers+ARB, another 2 (2.9 %) patients were prescribed with CCB+Diuretcs and 1 (1.5%) was prescribed with β-Blockers+diuretics. 
DISCUSSION
We studied patterns of antihypertensive use in patients with diabetes and hypertension, to evaluate whether they were consistent with evidence-based practice guidelines.
In present study, ACEI, ARBs and calcium channel blocker were more commonly prescribed drugs, followed by, diuretics and beta-blockers irrespective of mono or poly therapy. Majority of patients were on polytherapy in the present study. As the hypertensive patients were diabetic increased utilization of ACE inhibitors was observed which was in accordance with JNC-7 guidelines which recommend its use for renoprotection in the hypertensive diabetic patients 13 . Among all the ACEI, perindropirl (34.2%) was widely prescribed than any other ACEI. This finding is supported by the EUROPA study which indicated that among patients with stable coronary heart disease without apparent heart failure, perindopril can significantly improve outcome 14 .
We found that men were significantly more likely to be prescribed an ACE inhibitor as initial antihypertensive therapy than women (54.4 vs. 21%) this may be due to the fact that men are at high risk of developing atherosclerosis compared to women and also because of the teratogenic risk of ACEI and also reports from clinical trials have consistently documented that women are at higher risk of ACE inhibi- . In our present study use of multiple drug combinations for controlling blood pressure was also high at 55% compared to those using single drug 44.9% in these patients. Our finding is similar to those observed by Anand et al. 19 and Gu et al. 20 who indicated that the increased use of multiple antihypertensive drugs apparently has contributed to substantial improvement in BP control in the treated hypertensive population. A combination of diuretics and ACE inhibitor (ACEI) were the important drug combination to be most commonly prescribed in our study and also diuretics were used more often as component of multidrug therapy. This is supported by a previous report which indicated that ACEI-diuretic combinations achieve blood pressure control in approximately 80 percent of patients 21 .
In the present investigation, two-drug combinations were mostly prescribed (45.63%), followed by three-drug combinations (8.27%) and four drug combinations (0.67%) (Table 4 ). In two-drug combinations, a diuretic with ACEI (25%) and calcium channel blocker with angiotensin receptor blocker (25%) was most commonly prescribed as it is a choice for the treatment of the majority of patients with hypertension, particularly those at high risk of a secondary event 22 , the combined therapy with an ARB and a CCB has a potentially useful antiproteinuric effect in patients with type 2 diabetic nephropathy, even when their renal function is reduced 23 followed by an ARB with a diuretic (19.1 %). ONEAST study results confirm that ARB / diuretic combinations reduce BP further than monotherapies in hypertensive diabetic subjects with an acceptable safety profile 23 .
CONCLUSIONS
Although this study lacks both breadth and depth, however it provides a reasonable indication of the prescription patterns of antihypertensive agents in diabetic hypertensive population. Our findings suggest that CCBs and ACE inhibitors were used in large proportion of diabetic hypertensive patients and the pattern of antihypertensive therapy was generally consistent with JNC 7 guidelines, those being the current guidelines at the time of our study.
However, there remains potential room for improvement in drug utilization and a critical need for better blood pressure control. Further research is needed to qualify rationale for choice of drug based on demographic data, economic status, concomitant conditions and complications to give additional insight into prescribing patterns of antihypertensive in diabetic patients of Aseer region of Saudi Arabia.
